• Go to navigation
  • Go to content
AZ Brixham Laboratories

You are here

  • Home
  • Brixham Environmental Laboratory Testing

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • News Archive
  • Introduction to Brixham Environmental Laboratory
  • Services to Industry
  • Laboratory Capabilities
  • Innovative Environmental Science & Technologies
  • Useful Links
  • Free Resources
  • Find us
  • Contact
  • Download a brochure
  • Study Information Request
  • Sitemap
  • A-Z Index
  • REACH Seminar Presentations now available for viewing
  • REACH Testing Alliance
  • SETAC posters for downloading

Brixham Environmental Laboratory for all your Environmental Testing Requirements

Hands writing
Published date :
Aug 8, 2009
Expired date :
Dec 1, 2009

Here at Brixham Environmental Laboratory we are exploiting our already world-wide reputation for offering top quality, competitively priced testing. Our capacity to offer a wide range of expertise to our clients has expanded following our £12 million laboratory refurbishment and expansion.

Added to this, a range of efficiency improvements has enabled us to streamline many of our activities and we have capacity in many testing areas, including

  • Long and short term fate and ecotox studies, including Endocrine Disruption, Bioconcentration (OECD 305) and Persistence testing (OECD 303, OECD 308, OECD 309)
  • Full range of Ecotoxicity studies (algae, daphnia and fish)
  • Intelligent Testing and tailored studies
  • High performance liquid chromatography (HPLC) coupled with mass spectometry (LC/MS/MS)
  • Computer Modelling

Contact the Laboratory for a discussion with an expert of your environmental testing needs.

  • Advanced search

Quick links

  • AstraZeneca International
  • REACH Testing Consortium
  • News from Chemical Watch
  • Contact Us for REACH Testing
  • What our customers have to say about us

Page tools

  • Print
  • Bookmark this page
AstraZeneca

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2009